Thank you for visiting the healthcare professional section of http://www.4FLOMAX.com/. As you know, BPH is a prevalent medical condition that is largely undiagnosed and undetected,1 and we are pleased to support you in your efforts to diagnose and treat BPH in your patients. This site provides information about BPH and lower urinary tract symptoms (LUTS), as well as information about the efficacy, safety profile and dosing of FLOMAX. It also includes helpful tips on discussing BPH with your patients, useful screening tools and a variety of resources - including patient education materials. You will also find additional clinical information about FLOMAX for you and your colleagues. Just choose from the custom links below, or use the navigation at left to browse the entire site.
Helpful topics on this site for Primary Care Physicians:
- Diagnosing BPH
- Starting the Conversation with Your Patients
- FLOMAX Efficacy
- BPH Basics
- Resources for Your Practice
Not a Primary Care Physician? Click Here
Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid driving or hazardous tasks for 12 hours after their first dose or increase in dose should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.
Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.
Before prescribing FLOMAX, please see the full Prescribing Information.
1. Decision Resources Patient Base. Data accessed on July 18, 2006.
